Share Email Print

Proceedings Paper

Antimicrobial photodynamic therapy: from basis to clinical applications
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Antimicrobial photodynamic therapy (APDT) combines the use of light with a photosensitizer (PS) and oxygen to kill microbial cells. Even though this technique was first reported in the beginning of the 20th century, APDT never took off as antimicrobial chemotherapy did. However, microbial resistance to chemotherapy is currently expanding in faster rates than drug discovery. Therefore, introduction of therapeutic alternatives that bypass mechanisms of drug resistance now presents an urgent status. Fortunately, the scientific and technological development related to APDT made it far more feasible for mainstream clinical applications. Our research group has been working on mechanisms and applications of APDT for almost 20 years. We have already reported that successful APDT results depend on a number of factors, such as PS and light parameters, cell type, and oxygen abundance, among others. We have also demonstrated that APDT is an effective adjuvant in endodontics and periodontics and can be a non-invasive treatment for caries, candidiasis and cutaneous leishmaniasis. In Veterinary Medicine, we have reported effective treatment for penguin pododermatitis, snake stomatitis and dog otitis. This presentation will give an integrated perspective from the basic APDT mechanisms, preclinical and clinical trials to protocol optimization and future perspectives.

Paper Details

Date Published: 7 August 2019
PDF: 9 pages
Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 1107048 (7 August 2019); doi: 10.1117/12.2527918
Show Author Affiliations
Martha S. Ribeiro, IPEN-CNEN/SP (Brazil)
Caetano P. Sabino, BioLambda, Scientific and Commercial Ltd. (Brazil)
Univ. of São Paulo (Brazil)
Silvia Cristina Núñez, Brazil Univ. (Brazil)

Published in SPIE Proceedings Vol. 11070:
17th International Photodynamic Association World Congress
Tayyaba Hasan, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?